Inmode Ltd

NASDAQ:INMD  
43.63
+0.04 (+0.09%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.60B
Current PE27.64
Forward PE 25.97
2yr Forward PE 20.78
See more stats
Estimates Current Quarter
Revenue$63.72 Million
Adjusted EPS$0.58
See more estimates
10-Day MAN/A
50-Day MAN/A
200-Day MAN/A
See more pivots

InMode Ltd. Stock, NASDAQ:INMD

TAVOR BUILDING, SHA?AR YOKNEAM, POB 533, YOKNEAM, ISRAEL 2069200
Israel
Phone: 972-4-9097470
Number of Employees:

Description

InMode Ltd. designs, develops, manufactures, and markets minimally-invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radio frequency technologies. The company offers minimally-invasive aesthetic medical products for procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions. InMode Ltd. offers its products directly in the United States, Canada, the United Kingdom, Spain, India, and Australia, as well as indirectly through third-party distributors internationally. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was founded in 2008 and is headquartered in Yokneam, Israel.